The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages-Reference-Cited by-同舟云学术

The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages

Published:2020-02-07 Issue:3 Volume:31 Page:283-290
ISSN:0957-5243
Container-title:Cancer Causes & Control
language:en
Short-container-title:Cancer Causes Control

Author:

Knipper Sophie,Pecoraro Angela,Palumbo Carlotta,Rosiello Giuseppe,Luzzago Stefano,Deuker Marina,Tian Zhe,Shariat Shahrokh F.,Saad Fred,Tilki Derya,Graefen Markus,Karakiewicz Pierre I.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10552-020-01273-5.pdf

Reference17 articles.

1. Bechis SK, Carroll PR, Cooperberg MR (2011) Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol 29(2):235–241

2. Pettersson A, Robinson D, Garmo H, Holmberg L, Stattin P (2018) Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study. Ann Oncol 29(2):377–385

3. Abdollah F, Sun M, Thuret R, Jeldres C, Tian Z, Briganti A et al (2011) A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988–2006. Eur Urol 59(1):88–95

4. Mandel P, Kriegmair MC, Kamphake JK, Chun FK-H, Graefen M, Huland H et al (2016) Tumor characteristics and oncologic outcome after radical prostatectomy in men 75 years old or older. J Urol 196(1):89–94

5. Bratt O, Folkvaljon Y, Hjälm Eriksson M, Akre O, Carlsson S, Drevin L et al (2015) Undertreatment of men in their seventies with high-risk nonmetastatic prostate cancer. Eur Urol 68(1):53–58

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time trends in the use of curative treatment in men 70 years and older with nonmetastatic prostate cancer;Acta Oncologica;2024-03-20

2. p16 Immunohistochemical Expression in Nephrogenic Adenoma;Cureus;2023-07-02

3. PARP Inhibitors in the Management of BRCA-Positive Prostate Cancer: An Overview;Uro;2023-01-19

4. Strahlentherapie in der geriatrischen Urologie;Die Urologie;2023

5. Low-Dose Enzalutamide in Metastatic Prostate Cancer—Longevity Over Conventional Survival Analysis;Clinical Genitourinary Cancer;2022-12